Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 3
2019 1
2020 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
In Reply.
Brandi G, Deserti M, Vasuri F, Farioli A, Degiovanni A, Palloni A, Frega G, Barbera MA, de Lorenzo S, Garajova I, Di Marco M, Pinna AD, Cescon M, Cucchetti A, Ercolani G, D'Errico-Grigioni A, Pantaleo MA, Biasco G, Tavolari S. Brandi G, et al. Among authors: deserti m. Oncologist. 2016 Dec;21(12):e5-e6. doi: 10.1634/theoncologist.2016-0286. Epub 2016 Nov 2. Oncologist. 2016. PMID: 27807301 Free PMC article.
Adjuvant treatment in biliary tract cancer.
Palloni A, Frega G, De Lorenzo S, Rizzo A, Abbati F, Deserti M, Tavolari S, Brandi G. Palloni A, et al. Among authors: deserti m. Transl Cancer Res. 2019 Apr;8(Suppl 3):S289-S296. doi: 10.21037/tcr.2018.08.17. Transl Cancer Res. 2019. PMID: 35117108 Free PMC article. Review.
PARP Inhibitors in Biliary Tract Cancer: A New Kid on the Block?
Ricci AD, Rizzo A, Bonucci C, Tober N, Palloni A, Mollica V, Maggio I, Deserti M, Tavolari S, Brandi G. Ricci AD, et al. Among authors: deserti m. Medicines (Basel). 2020 Aug 31;7(9):54. doi: 10.3390/medicines7090054. Medicines (Basel). 2020. PMID: 32878011 Free PMC article. Review.
Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies.
Brandi G, Relli V, Deserti M, Palloni A, Indio V, Astolfi A, Serravalle S, Mattiaccio A, Vasuri F, Malvi D, Deiana C, Pantaleo MA, Cescon M, Rizzo A, Katoh M, Tavolari S. Brandi G, et al. Among authors: deserti m. Sci Rep. 2024 Feb 7;14(1):3136. doi: 10.1038/s41598-024-52991-8. Sci Rep. 2024. PMID: 38326380 Free PMC article.
Membrane Localization of Human Equilibrative Nucleoside Transporter 1 in Tumor Cells May Predict Response to Adjuvant Gemcitabine in Resected Cholangiocarcinoma Patients.
Brandi G, Deserti M, Vasuri F, Farioli A, Degiovanni A, Palloni A, Frega G, Barbera MA, de Lorenzo S, Garajova I, Di Marco M, Pinna AD, Cescon M, Cucchetti A, Ercolani G, D'Errico-Grigioni A, Pantaleo MA, Biasco G, Tavolari S; G.I.CO. (Gruppo Italiano Colangiocarcinoma). Brandi G, et al. Among authors: deserti m. Oncologist. 2016 May;21(5):600-7. doi: 10.1634/theoncologist.2015-0356. Epub 2016 Mar 31. Oncologist. 2016. PMID: 27032872 Free PMC article.